Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep;19(9):1040-1048.
doi: 10.1038/gim.2016.224. Epub 2017 Mar 2.

The Exome Clinic and the role of medical genetics expertise in the interpretation of exome sequencing results

Dustin Baldridge  1 , Jennifer Heeley  1   2 , Marisa Vineyard  1 , Linda Manwaring  1 , Tomi L Toler  1 , Emily Fassi  1 , Elise Fiala  1 , Sarah Brown  3 , Charles W Goss  4 , Marcia Willing  1 , Dorothy K Grange  1 , Beth A Kozel  1   5 , Marwan Shinawi  1
Affiliations

The Exome Clinic and the role of medical genetics expertise in the interpretation of exome sequencing results

Dustin Baldridge et al. Genet Med. 2017 Sep.

Abstract

Purpose: Evaluation of the clinician's role in the optimal interpretation of clinical exome sequencing (ES) results.

Methods: Retrospective chart review of the first 155 patients who underwent clinical ES in our Exome Clinic and direct interaction with the ordering geneticist to evaluate the process of interpretation of results.

Results: The most common primary indication was neurodevelopmental problems (~66%), followed by multiple congenital anomalies (~10%). Based on sequencing data, the overall diagnostic yield was 36%. After assessment by the medical geneticist, incorporation of detailed phenotypic and molecular data, and utilization of additional diagnostic modalities, the final diagnostic yield increased to 43%. Seven patients in our cohort were included in initial case series that described novel genetic syndromes, and 23% of patients were involved in subsequent research studies directly related to their results or involved in efforts to move beyond clinical ES for diagnosis. Clinical management was directly altered due to the ES findings in 12% of definitively diagnosed cases.

Conclusions: Our results emphasize the usefulness of ES, demonstrate the significant role of the medical geneticist in the diagnostic process of patients undergoing ES, and illustrate the benefits of postanalytical diagnostic work-up in solving the "diagnostic odyssey." Genet Med advance online publication 02 March 2017.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Cost and phenotypic characterization of the cohort
A) Scatter plot of the out-of-pocket cost in ascending order. B) Each case was assigned a phenotype-based, single primary indication for performing ES. The number and percentage of cases are shown in parenthesis. MCA: Multiple congenital anomalies. C) Each phenotypic feature of the probands was assigned to an organ system, and the total count of cases is displayed. D) The frequency and distribution of the neurodevelopmental phenotypes in the cohort. The darker portion of the bar in C and D indicates the proportion of cases that achieved a definitive diagnosis.
Figure 2
Figure 2. Characterization of case-level and clinical-level assertions
A) The relative percentages of each case-level classification as reported by the testing laboratory. B) The diagnostic rates according to case-level and clinical-level assertions are shown as the proportion of cases, in gray. The change in classification of cases is indicated, with 16 cases promoted and 5 demoted.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing. The New England journal of medicine. 2014;370(25):2418–2425. - PubMed
    1. Bamshad MJ, Ng SB, Bigham AW, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nature reviews Genetics. 2011;12(11):745–755. - PubMed
    1. Yang Y, Muzny DM, Xia F, et al. Molecular findings among patients referred for clinical whole-exome sequencing. Jama. 2014;312(18):1870–1879. - PMC - PubMed
    1. Lee H, Deignan JL, Dorrani N, et al. Clinical exome sequencing for genetic identification of rare Mendelian disorders. Jama. 2014;312(18):1880–1887. - PMC - PubMed
    1. Farwell KD, Shahmirzadi L, El-Khechen D, et al. Enhanced utility of family-centered diagnostic exome sequencing with inheritance model-based analysis: results from 500 unselected families with undiagnosed genetic conditions. Genetics in medicine : official journal of the American College of Medical Genetics. 2015;17(7):578–586. - PubMed

Publication types

-